207 related articles for article (PubMed ID: 19832978)
1. The l1-l2 regularization framework unmasks the hypoxia signature hidden in the transcriptome of a set of heterogeneous neuroblastoma cell lines.
Fardin P; Barla A; Mosci S; Rosasco L; Verri A; Varesio L
BMC Genomics; 2009 Oct; 10():474. PubMed ID: 19832978
[TBL] [Abstract][Full Text] [Related]
2. Identification of multiple hypoxia signatures in neuroblastoma cell lines by l1-l2 regularization and data reduction.
Fardin P; Cornero A; Barla A; Mosci S; Acquaviva M; Rosasco L; Gambini C; Verri A; Varesio L
J Biomed Biotechnol; 2010; 2010():878709. PubMed ID: 20652058
[TBL] [Abstract][Full Text] [Related]
3. A biology-driven approach identifies the hypoxia gene signature as a predictor of the outcome of neuroblastoma patients.
Fardin P; Barla A; Mosci S; Rosasco L; Verri A; Versteeg R; Caron HN; Molenaar JJ; Ora I; Eva A; Puppo M; Varesio L
Mol Cancer; 2010 Jul; 9():185. PubMed ID: 20624283
[TBL] [Abstract][Full Text] [Related]
4. Artificial neural network classifier predicts neuroblastoma patients' outcome.
Cangelosi D; Pelassa S; Morini M; Conte M; Bosco MC; Eva A; Sementa AR; Varesio L
BMC Bioinformatics; 2016 Nov; 17(Suppl 12):347. PubMed ID: 28185577
[TBL] [Abstract][Full Text] [Related]
5. Use of Attribute Driven Incremental Discretization and Logic Learning Machine to build a prognostic classifier for neuroblastoma patients.
Cangelosi D; Muselli M; Parodi S; Blengio F; Becherini P; Versteeg R; Conte M; Varesio L
BMC Bioinformatics; 2014; 15 Suppl 5(Suppl 5):S4. PubMed ID: 25078098
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional adaptation of neuroblastoma cells to hypoxia.
Fredlund E; Ovenberger M; Borg K; Påhlman S
Biochem Biophys Res Commun; 2008 Feb; 366(4):1054-60. PubMed ID: 18155155
[TBL] [Abstract][Full Text] [Related]
7. Design of a multi-signature ensemble classifier predicting neuroblastoma patients' outcome.
Cornero A; Acquaviva M; Fardin P; Versteeg R; Schramm A; Eva A; Bosco MC; Blengio F; Barzaghi S; Varesio L
BMC Bioinformatics; 2012 Mar; 13 Suppl 4(Suppl 4):S13. PubMed ID: 22536959
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of transcriptomics based hypoxia signatures in head- and neck squamous cell carcinoma.
Tawk B; Schwager C; Deffaa O; Dyckhoff G; Warta R; Linge A; Krause M; Weichert W; Baumann M; Herold-Mende C; Debus J; Abdollahi A
Radiother Oncol; 2016 Feb; 118(2):350-8. PubMed ID: 26711490
[TBL] [Abstract][Full Text] [Related]
9. Integrative genomics reveals hypoxia inducible genes that are associated with a poor prognosis in neuroblastoma patients.
Applebaum MA; Jha AR; Kao C; Hernandez KM; DeWane G; Salwen HR; Chlenski A; Dobratic M; Mariani CJ; Godley LA; Prabhakar N; White K; Stranger BE; Cohn SL
Oncotarget; 2016 Nov; 7(47):76816-76826. PubMed ID: 27765905
[TBL] [Abstract][Full Text] [Related]
10. A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition.
Mak MP; Tong P; Diao L; Cardnell RJ; Gibbons DL; William WN; Skoulidis F; Parra ER; Rodriguez-Canales J; Wistuba II; Heymach JV; Weinstein JN; Coombes KR; Wang J; Byers LA
Clin Cancer Res; 2016 Feb; 22(3):609-20. PubMed ID: 26420858
[TBL] [Abstract][Full Text] [Related]
11. In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer.
Abu-Jamous B; Buffa FM; Harris AL; Nandi AK
Mol Cancer; 2017 Jun; 16(1):105. PubMed ID: 28619028
[TBL] [Abstract][Full Text] [Related]
12. A NOTCH3 transcriptional module induces cell motility in neuroblastoma.
van Nes J; Chan A; van Groningen T; van Sluis P; Koster J; Versteeg R
Clin Cancer Res; 2013 Jul; 19(13):3485-94. PubMed ID: 23649002
[TBL] [Abstract][Full Text] [Related]
13. Identification of gene signatures from RNA-seq data using Pareto-optimal cluster algorithm.
Mallik S; Zhao Z
BMC Syst Biol; 2018 Dec; 12(Suppl 8):126. PubMed ID: 30577846
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of PDK1, PHD3 and HIF-1α expression defines the hypoxic status of neuroblastoma tumors.
Ognibene M; Cangelosi D; Morini M; Segalerba D; Bosco MC; Sementa AR; Eva A; Varesio L
PLoS One; 2017; 12(11):e0187206. PubMed ID: 29117193
[TBL] [Abstract][Full Text] [Related]
15. Accurate outcome prediction in neuroblastoma across independent data sets using a multigene signature.
De Preter K; Vermeulen J; Brors B; Delattre O; Eggert A; Fischer M; Janoueix-Lerosey I; Lavarino C; Maris JM; Mora J; Nakagawara A; Oberthuer A; Ohira M; Schleiermacher G; Schramm A; Schulte JH; Wang Q; Westermann F; Speleman F; Vandesompele J
Clin Cancer Res; 2010 Mar; 16(5):1532-41. PubMed ID: 20179214
[TBL] [Abstract][Full Text] [Related]
16. Hydra: A mixture modeling framework for subtyping pediatric cancer cohorts using multimodal gene expression signatures.
Pfeil J; Sanders LM; Anastopoulos I; Lyle AG; Weinstein AS; Xue Y; Blair A; Beale HC; Lee A; Leung SG; Dinh PT; Shah AT; Breese MR; Devine WP; Bjork I; Salama SR; Sweet-Cordero EA; Haussler D; Vaske OM
PLoS Comput Biol; 2020 Apr; 16(4):e1007753. PubMed ID: 32275708
[TBL] [Abstract][Full Text] [Related]
17. Gene Expression Signatures as Biomarkers of Tumour Hypoxia.
Harris BH; Barberis A; West CM; Buffa FM
Clin Oncol (R Coll Radiol); 2015 Oct; 27(10):547-60. PubMed ID: 26282471
[TBL] [Abstract][Full Text] [Related]
18. Subclassification and individual survival time prediction from gene expression data of neuroblastoma patients by using CASPAR.
Oberthuer A; Kaderali L; Kahlert Y; Hero B; Westermann F; Berthold F; Brors B; Eils R; Fischer M
Clin Cancer Res; 2008 Oct; 14(20):6590-601. PubMed ID: 18927300
[TBL] [Abstract][Full Text] [Related]
19. Double Selection Based Semi-Supervised Clustering Ensemble for Tumor Clustering from Gene Expression Profiles.
Yu Z; Chen H; You J; Wong HS; Liu J; Li L; Han G
IEEE/ACM Trans Comput Biol Bioinform; 2014; 11(4):727-40. PubMed ID: 26356343
[TBL] [Abstract][Full Text] [Related]
20. Combining biological gene expression signatures in predicting outcome in breast cancer: An alternative to supervised classification.
Nuyten DS; Hastie T; Chi JT; Chang HY; van de Vijver MJ
Eur J Cancer; 2008 Oct; 44(15):2319-29. PubMed ID: 18715778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
